Xinlitai announced that due to the repurchase clause of the original agreement, the company plans to repurchase part of the shares of Xintai Medical's holding subsidiary: transfer 7.0863.21 million shares of Xintai Medical held by Xinshi Xinxing, with a transfer price of 426 million yuan; transfer 121.68 million shares of Xintai Medical held by Xinshi Xinjie, with a transfer price of 7063 million yuan. After the repurchase is completed, the company's shareholding ratio of Xintai Medical will rise from 87.3639% to 93.5063%. Xintai Medical is still a holding subsidiary within the scope of the company's consolidated statements. The repurchase capital is self-funded by the company and will not affect production, operation and funding arrangements.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.